No link between soluble CD40 ligand and subclinical atherosclerosis
Claire Braybrook
This article has no abstract so we have provided the first paragraph of the full text.
Soluble CD40 ligand (sCD40L) is not associated with most coronary disease risk factors or with subclinical atherosclerosis, results from the Dallas Heart Study have revealed.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
